• head_banner_01

Massive Selection for 25 Sorafenib - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We offer fantastic strength in high quality and enhancement,merchandising,income and marketing and procedure for Rad001, Sodium Stearate, Natrium Acetate, Good quality is factory' existence , Focus on customer' demand is the source of company survival and advancement, We adhere to honesty and superior faith working attitude, hunting forward towards your coming !
Massive Selection for 25 Sorafenib - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex Detail:

Product Detail

NO.

Products

CAS No.

 Application

Key Quality Indicator

Purity

Isomer

SI *

Max *

Moisture

1

Fmoc-Lys(Mtt)-OH 167393-62-6 Lysine side chain modification

≥99.0%

≤0.1%

≤0.2%

≤0.3%

≤1.0%

2

Fmoc-Lys(Alloc)-OH 146982-27-6 Lysine side chain modification

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

3

Fmoc-Lys(ivDde)-OH 150629-67-7 Lysine side chain modification

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

4

Fmoc-Lys(Mmt)-OH 159857-60-0 Lysine side chain modification

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

5

Fmoc-Glu-OtBu 84793-07-7 LiraglutideSemaglutide

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

6

Glu-OtBu 45120-30-7 LiraglutideSemaglutide

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

7

Octadecanedioic acid 871-70-5 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

8

Octadecanedioic acid   mono-tert-butyl ester 843666-40-0 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

9

tBu-OOC-C16-CO-Glu-OtBu 1188328-39-3 SemaglutideFragment A

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

10

AEEA 134978-97-5 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

11

AEEA-OH.HCl 134979-01-4 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

12

Fmoc-AEEA-OH 166108-71-0 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

13

Boc-AEEA-OH 108466-89-3 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

14

AEEA-AEEA 1143516-05-5 Semaglutide

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

15

Fmoc-AEEA-AEEA-OH 560088-89-3 SemaglutideFragment B

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

16

Octa(OtBu)-Glu(ɑ-OtBu)-AEEA-AEEA-OH 1118767-16-0 SemaglutideFragment C

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

17

tBu-OOC-C16-CO-Glu(AEEA-AEEA-NHS)-OtBu 1118767-15-9 SemaglutideFragment D

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

18

Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH 1662688-20-1 Semaglutide Fragment E

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

19

Boc-His(Trt)-OH 32926-43-5 The end is histidine

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤4.0%

20

Fmoc-Aib-OH 94744-50-0 Semaglutide

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

21

Boc-His(Trt)-Aib-OH 2061897-68-3 Semaglutide

≥99.0%

≤0.1%

≤0.2%

≤0.3%

≤2.0%

22

Fmoc-Glu(OtBu)-Gly-OH 866044-63-5 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

23

Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH 1169630-31-2? Semaglutide Fragment F

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

24

Boc-His(Trt)-Aib-Glu(OtBu)-Gly-NHS 1169630-40-3 Semaglutide Fragment G

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

25

Fmoc-Arg(pbf)-Gly-OH 660846-80-0 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

26

Fmoc-Ala-Ala-OH 87512-31-0 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

27

Fmoc-Thr(tBu)-Phe-OH 1260609-75-3 ? GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

28

Palmitic acid 1957/10/3 Liraglutide Fragment 1

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

29

Palm-Glu-OtBu NA Liraglutide Fragment 2

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

30

Palm-Glu(NES)-OtBu NA Liraglutide Fragment 3

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

31

Fmoc-Lys(Palm-Glu-OtBu)-OH 1491158-62-3 Liraglutide

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

32

Hexadecanedioic acid 505-54-4 Insulin degludec

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

33

Hexadecanedioic acid   mono-tert-butyl ester 843666-27-3 Insulin degludec

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

34

tBu-OOC-C14-CO-Glu-OtBu NA Insulin degludec Fragment I

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

35

tBu-OOC-C14-CO-Glu(NES)-OtBu NA Insulin degludec Fragment II

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

SI *= Specific Impurity

Max*= Max Unknown Impurity

Other Indicator:

- Acetic Acid: ≤0.02% (All Products)

- Ethyl Acetate: ≤0.5% (All Products)

- Alcohol: ≤0.5% (All Products)

Sanitization

Sanitization of distribution system, including loop and storage tank is performed by Pasteurization. When Pasteurization sanitization is performed, the purified water in tank is heated up to 80°C and start to circulate by distribution system. The sanitization lasts 1 hour after reaching 80°C. Sanitization is performed every quarter. The purified water system sanitization logbook was checked with no excursion highlighted.


Product detail pictures:

Massive Selection for 25 Sorafenib - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex detail pictures


Related Product Guide:

We support our consumers with ideal good quality merchandise and large level provider. Becoming the specialist manufacturer in this sector, we have attained wealthy practical encounter in producing and managing for Massive Selection for 25 Sorafenib - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex , The product will supply to all over the world, such as: United States, Hungary, New Delhi, Our products have been obtained more and more recognition from foreign clients, and established long term and cooperative relationship with them. We`ll provide the best service for every customer and sincerely welcome friends to work with us and establish the mutual benefit together.
  • This company conforms to the market requirement and joins in the market competition by its high quality product, this is an enterprise that have Chinese spirit.
    5 Stars By Princess from Denver - 2017.02.18 15:54
    Factory equipment is advanced in the industry and the product is fine workmanship, moreover the price is very cheap, value for money!
    5 Stars By Betsy from Riyadh - 2017.03.28 12:22
    Write your message here and send it to us